Biblio
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation. Front Oncol. 2023;13:1230629.
. A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea. Int J Hematol. 2022.
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.
Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in Korea. Clin Lymphoma Myeloma Leuk. 2022.
. .
.
Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2013.
Plerixafor use for peripheral blood stem cell mobilization in Korea. Blood Res. 2013;48(2):72-3.
.